- PROJECT 1 One of the most common chronic diseases in the United States, asthma is a syndrome of airway inflammation and airflow obstruction. The presence of high levels of inducible nitric oxide synthase (iNOS), which produces NO and citrulline from arginine, and arginase, which converts arginine to ornithine and citrulline, suggest that asthma is a state of increased arginine catabolism. However, our prior work showed that arginine levels in asthma airway epithelium are 3-fold higher than in healthy airways. Little is known of arginine flux through iNOS and arginase pathways, the mechanisms that sustain arginine availability for these highly active pathways, or the consequences of increased arginine flux for asthma pathobiology. Here, preliminary studies reveal a cell-autonomous cycle for arginine synthesis, the citrulline-NO cycle, in which Tricarboxylic Acid (TCA) cycle intermediates shuttle nitrogen (N) to citrulline for the regeneration of arginine. We find that mitochondrial arginase 2 (ARG2) is higher in asthmatic airway epithelium as compared to controls, and does not compete with iNOS for arginine. Rather, ARG2 accelerates oxidative bioenergetic pathways, and suppresses levels of hypoxia inducible factors (HIF) that are mechanistically important in regulation of interleukin (IL)-13, a key cytokine in development of asthma. ARG2 blocks HIF accumulation, inhibits IL-13 production and prevents mucus metaplasia. Mice deficient in ARG2 have more IL-13 and mucus metaplasia in an allergen model of asthma, suggesting that arginine metabolism modulates cell physiology. Sub-classification of asthmatics by exhaled NO levels and genetic variants of ARG2, reveal arginine metabolic endotypes of asthma that quantitatively relate to subphenotypes of asthma. All this caused us to consider that arginine pathways may mechanistically modulate asthma inflammation in ways beyond the simple view of arginine as a source of NO. Thus, we propose to test the hypothesis that arginine flux through iNOS in the cytosol and ARG2 in the mitochondria regulates cell bioenergetics and HIF levels, and consequently modulates airway epithelial IL-13 production and mucus metaplasia. Working with Projects 2-4, we identify arginine metabolic pathways in the airways [Aim 1], determine if arginine flux acts as a checkpoint for aerobic metabolism and HIF accumulation [Aim 2], and regulates airway inflammation, mucus metaplasia and asthma severity [Aim 3]. Project 1 depends on interactions, expertise, and resources of the Program to test these hypotheses. Program Cores support murine models, technically complex assays, and shared clinical samples in order to facilitate translational and mechanistic experiments, not otherwise possible.

Public Health Relevance

- PROJECT 1 Asthma is a chronic inflammation of the airways that is characterized by airflow obstruction. Our studies investigate abnormalities in metabolism of the amino acid arginine, that contribute to asthmatic airway inflammation and mucus secretion. Understanding how metabolism regulates inflammation will allow us to design new strategies for future therapeutic interventions

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Program Projects (P01)
Project #
5P01HL081064-09
Application #
9418074
Study Section
Heart, Lung, and Blood Initial Review Group (HLBP)
Program Officer
Noel, Patricia
Project Start
Project End
Budget Start
2018-02-01
Budget End
2019-01-31
Support Year
9
Fiscal Year
2018
Total Cost
Indirect Cost
Name
Cleveland Clinic Lerner
Department
Type
DUNS #
135781701
City
Cleveland
State
OH
Country
United States
Zip Code
44195
Dai, Yue; Haque, Mohammad Mahfuzul; Stuehr, Dennis J (2017) Restricting the conformational freedom of the neuronal nitric-oxide synthase flavoprotein domain reveals impact on electron transfer and catalysis. J Biol Chem 292:6753-6764
Ghosh, Arnab; Stuehr, Dennis J (2017) Regulation of sGC via hsp90, Cellular Heme, sGC Agonists, and NO: New Pathways and Clinical Perspectives. Antioxid Redox Signal 26:182-190
Xu, Weiling; Comhair, Suzy A A; Janocha, Allison J et al. (2017) Arginine metabolic endotypes related to asthma severity. PLoS One 12:e0183066
Kartha, Ganesh K; Li, Ina; Comhair, Suzy et al. (2017) Co-Occurrence of Asthma and Nephrolithiasis in Children. PLoS One 12:e0168813
Husta, Bryan C; Raoof, Suhail; Erzurum, Serpil et al. (2017) Tracheobronchopathy From Inhaled Corticosteroids. Chest 152:1296-1305
Zein, Joe G; Love, Thomas E; Erzurum, Serpil C (2017) Asthma Is Associated with a Lower Risk of Sepsis and Sepsis-related Mortality. Am J Respir Crit Care Med 196:787-790
Jang, Eunjung; Nguyen, Quang Tam; Kim, Sohee et al. (2017) Lung-Infiltrating Foxp3+ Regulatory T Cells Are Quantitatively and Qualitatively Different during Eosinophilic and Neutrophilic Allergic Airway Inflammation but Essential To Control the Inflammation. J Immunol 199:3943-3951
Hwangbo, Cheol; Lee, Heon-Woo; Kang, Hyeseon et al. (2017) Modulation of Endothelial Bone Morphogenetic Protein Receptor Type 2 Activity by Vascular Endothelial Growth Factor Receptor 3 in Pulmonary Arterial Hypertension. Circulation 135:2288-2298
Stober, Vandy P; Johnson, Collin G; Majors, Alana et al. (2017) TNF-stimulated gene 6 promotes formation of hyaluronan-inter-?-inhibitor heavy chain complexes necessary for ozone-induced airway hyperresponsiveness. J Biol Chem 292:20845-20858
Ghosh, Arnab; Koziol-White, Cynthia J; Asosingh, Kewal et al. (2016) Soluble guanylate cyclase as an alternative target for bronchodilator therapy in asthma. Proc Natl Acad Sci U S A 113:E2355-62

Showing the most recent 10 out of 114 publications